KYTX ▼ -0.4% - Kyverna Therapeutics, Inc.
$KYTX Reports Positive One-Year Data Demonstrating Durable Clinical Responses and Favorable Safety Profile for Miv-cel in Stiff Person Syndrome and Generalized Myasthenia Gravis
24-SEP-2026 06:02 AM ET
Share this post
More filings for $KYTX
KYTX ▼ -5.1% - Kyverna Therapeutics, Inc.Oct 23, 2026KYTX ▲ +1.0% - Kyverna Therapeutics, Inc.Oct 21, 2026KYTX - Kyverna Therapeutics, Inc. - SEC Filing Update (19-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 19, 2026KYTX ▲ +0.6% - Kyverna Therapeutics, Inc.Oct 7, 2026KYTX ▲ +1.6% - Kyverna Therapeutics, Inc.Sep 24, 2026KYTX ▲ +2.9% - Kyverna Therapeutics, Inc.Sep 2, 2026
View full $KYTX filing history →💬 Comments
Loading comments…
Leave a comment